Loading chat...

NJ S884

Bill

Status

Introduced

1/13/2026

Primary Sponsor

Michael Testa

Click for details

Origin

Senate

2026-2027 Regular Session

AI Summary

  • Prohibits New Jersey pension and annuity funds under the Division of Investment from investing in Chinese pharmaceutical companies or any company with equity ties or business operations with Chinese pharmaceutical companies
  • Defines "Chinese pharmaceutical company" as companies headquartered in China that are at least 51% owned by Chinese citizens, civilian-run enterprises, or the Chinese government
  • Requires the State Investment Council and Division of Investment to divest from any prohibited investments within three years of the bill's effective date
  • Mandates the Division of Investment to file a report within 60 days identifying all violating investments, followed by annual progress reports to the Legislature
  • Provides legal indemnification for State Investment Council members and state employees from any claims arising from investment decisions made under this law

Legislative Description

Prohibits investment by State of pension and annuity funds in Chinese pharmaceutical companies.

State Government, Wagering, Tourism & Historic Preservation

Last Action

Introduced in the Senate, Referred to Senate State Government, Wagering, Tourism & Historic Preservation Committee

1/13/2026

Committee Referrals

State Government, Wagering, Tourism & Historic Preservation1/13/2026

Full Bill Text

No bill text available